Alam J, Sarkar A, Karmakar BC, Ganguly M, Paul S, Mukhopadhyay AK. Novel virulence factor dupA of Helicobacter pylori as an important risk determinant for disease manifestation: An overview. World J Gastroenterol 2020; 26(32): 4739-4752 [PMID: 32921954 DOI: 10.3748/wjg.v26.i32.4739]
Corresponding Author of This Article
Asish K Mukhopadhyay, PhD, Senior Scientist, Division of Bacteriology, ICMR-National Institute of Cholera and Enteric Diseases, P 33, CIT Road, Scheme XM, Beliaghata, Kolkata 700010, India. firstname.lastname@example.org
Checklist of Responsibilities for the Scientific Editor of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Author contributions: Alam J and Mukhopadhyay AK was involved in the conceptualization; Alam J, Karmakar BC and Sarkar A were involved in the writing the original draft; Sarkar A and Paul S performed the methodology; Karmakar BC was involved in collecting research; Ganguly M took part in the visualization; Ganguly M and Paul S wrote and edited the review; Paul S performed the validation; Mukhopadhyay AK supervised, critically revised and edited the manuscript; All authors have read and approve the final manuscript.
Supported byCouncil of Scientific and Industrial Research, Government of India, No. 12458; Department of Science and Technology, India, No. IF140909; and the Council of Scientific and Industrial Research, India, No. 09/482(0065)/2017-EMR-1.
Conflict-of-interest statement: All authors declare no conflicts of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Asish K Mukhopadhyay, PhD, Senior Scientist, Division of Bacteriology, ICMR-National Institute of Cholera and Enteric Diseases, P 33, CIT Road, Scheme XM, Beliaghata, Kolkata 700010, India. email@example.com
Received: February 20, 2020 Peer-review started: February 20, 2020 First decision: February 29, 2020 Revised: June 23, 2020 Accepted: August 3, 2020 Article in press: August 3, 2020 Published online: August 28, 2020
Helicobacter pylori (H. pylori) is a microaerophilic, Gram-negative, human gastric pathogen found usually in the mucous lining of stomach. It infects more than 50% of the world’s population and leads to gastroduodenal diseases. The outcome of disease depends on mainly three factors: Host genetics, environment and bacterial factors. Among these, bacterial virulence factors such as cagA, vacA are well known for their role in disease outcomes. However, based on the global epidemiological results, none of the bacterial virulence (gene) factors was found to be associated with particular diseases like duodenal ulcer (DU) in all populations. Hence, substantial importance has been provided for research in strain-specific genes outside the cag pathogenicity island, especially genes located within the plasticity regions. dupA found within the plasticity regions was first demonstrated in 2005 and was proposed for duodenal ulcer development and reduced risk of gastric cancer in certain geographical regions. Due to the discrepancies in report from different parts of the world in DU development related to H. pylori virulence factor, dupA became an interesting area of research in elucidating the role of this gene in the disease progression. In this review, we shed light on the detailed information available on the polymorphisms in dupA and their clinical relevance. We have critically appraised several pertinent studies on dupA and discussed their merits and shortcomings. This review also highlights dupA gene as an important biomarker for DU in certain populations.
Core tip: A novel virulence factor dupA located in the plasticity region of Helicobacter pylori genome was found to be associated with duodenal ulcer development in certain geographical regions. Well-known bacterial virulence factors in this pathogen like cagA, vacA are not found to be associated with duodenal ulcer in Asia. Studies focused on the epidemiology and clinical relevance of dupA around the world exhibit significant variations. Hence, we focused on the variations in dupA and the plausible role of such variation in disease etiology with the goal of bringing attention to this topic to the scientific community and eventually opening up avenues for further research.
Citation: Alam J, Sarkar A, Karmakar BC, Ganguly M, Paul S, Mukhopadhyay AK. Novel virulence factor dupA of Helicobacter pylori as an important risk determinant for disease manifestation: An overview. World J Gastroenterol 2020; 26(32): 4739-4752
Helicobacter pylori (H. pylori) is a curved rod-shaped, Gram-negative, microaerophilic bacterium found usually in the mucous lining of the stomach. H. pylori infects more than 50% of the world’s population and 70%-80% of the Indian population[1,2]. H. pylori is acquired during childhood and remains in the stomach throughout the life if not treated effectively. Infection with H. pylori causes duodenal ulcer (DU), gastric ulcer (GU), gastric cancer (GC) and gastric mucosa-associated lymphoid tissue lymphoma[4-7]. Considering its clinical importance, the World Health Organization has declared H. pylori as a class I carcinogen and enlisted GC as the fifth most common cancer and the third most common cause of cancer-related death[8,9]. Infection of H. pylori is comparatively more prevalent in developing countries than Western countries due to socioeconomic and sanitary conditions. The mode of transmission of H. pylori is not clearly understood. However, most of the studies suggest that H. pylori is transmitted from person to person via oral-oral and fecal-oral route and also through contaminated food and water[11-14].
The enigma of H. pylori research is that the majority of infected patients remain asymptomatic, whereas around 15%-20% of infected individuals develop symptoms of peptic ulcer (duodenal or gastric) as a long-term consequence of infection. It is not clear what governs the manifestation of H. pylori infection in some people. This apparent puzzle prompted the proposal that the sheer presence of H. pylori in the stomach is inadequate to develop acute gastric disease and that other conditions are required. However, it is assumed that the responsible factors in H. pylori-associated diseases are due to its virulence factors, host genetics, immunity and environmental influences. Host factors like polymorphism in the genes (pro-inflammatory cytokine genes) increase the risk of the specific clinical outcome. None of the H. pylori virulence factors such as cagA, vacA, the blood group antigen babA and oipA have been linked with specific diseases like DU or GC uniformly in all populations[16-20].
Analysis of the full genome sequences of different H. pylori strains reported specific genetic locus whose G+C content was lower than that of the rest of the H. pylori genome. This indicates the possibility of horizontal deoxyribonucleic acid (DNA) transfer from other species. H. pylori carry an open pan-genome, which maintain a discrete group of strain-specific genes. These strain-specific genes mostly reside in genomic regions that had earlier been coined as plasticity zones. This term was previously used to describe a specific genetic segment with high variation between the H. pylori genome sequences[21,22]. The complete genome sequence of H. pylori reveals that part of the plasticity zone is normally arranged as genomic islands that may be integrated in the genetic loci. About 50% of the strain-specific genes of H. pylori are located in the plasticity region. Here, our focus is on the gene dupA, which is located within the plasticity region. This gene was first reported in 2005 as an important biomarker for DU. During subsequent years, several investigations were carried out on dupA, and this has become an interesting area of research, as shown in Table 1.
Table 1 Important finding on dupA of Helicobacter pylori in chronological order.
Observation and conclusion
Techniques used in the study
dupA was novel marker associated with increased risk for DU and reduced risk for gastric cancer in East Asia and South America
Found a positive association between presence of dupA and DU [OR 24.2; 95%CI: 10.6-54.8] and inverse association between presence of dupA and GU [OR 0.34; 95%CI: 0.16-0.68] and GC [OR 0.16; 95%CI: 0.05-0.47]
classified dupA into two types (long types and short types) depend on the presence of 615 bp at the N-terminal of dupA. Found high prevalence of intact long type dupA (24.5%) than short type dupA (6.6%) and significantly associated with GU and GC than gastritis (P = 0.001 and P = 0.019) in Japanese population
There was no significant relationship between dupA status and duodenal ulcer disease (P = 0.25) but, there was a converse relationship between dupA negative strains and gastric cancer disease (P = 0.02)
A complete tfs plasticity zone cluster including dupA is a virulence factor that may be important for the colonization of H. pylori and to the development of severe outcomes of the infection with cagA-positive strains
To review the importance of dupA, we have searched the “NCBI-PubMed” using the keywords: “dupA”, “H. pylori” and a total of 80 articles were found, of which 76 were published in English till January 2020. Out of 76, 13 are published as review articles and two as meta-analysis of previous data. The remaining 61 documented as research articles. The research on dupA has spanned 15 years with contradictory findings. In this review, we summarize the result of relevant studies and discuss the pathogenesis of dupA since its early stage to recent advancements. Finally, this review highlights the significance of dupA gene of H. pylori as a virulence factor (virulence marker) and its role in pathogenesis including the progression of DU.
DISCREPANCIES OF DUPA WITH CLINICAL OUTCOMES
Studies conducted with H. pylori strains from East Asia and South America identified a novel H. pylori virulence factor encoded in the dupA that was associated with increased risk of DU and decreased risk of GC. However, this perception seems to be region specific. This dupA was homologous to virB4 gene, located in the plasticity zone of H. pylori. dupA contained two open reading frames (ORFs), jhp0917 and jhp0918, with an overlap of twelve bases and an insertion of either base thymine (T) or cytosine (C) after the position 1385 of the jhp0917 that leads to continuous gene of 1839 bp. Since 2005, several studies have been conducted from different geographical areas to check the association of dupA with disease outcome considering the dupA has two ORFs (jhp0917/jhp0918) with the insertion of one base (T/C) at position 1385 of jhp0917. Studies performed in North India during 2007 support the finding of Lu et al. However, studies conducted in different countries (Belgium, South Africa, China, North America and Brazil) found that dupA is not associated with DU in the respective population[25-27].
Investigations made in Sao Paulo, Brazil showed that dupA was detected in H. pylori strains of 41.5% patients, which was less from a previous study made by Gomes et al (2008), in which dupA was present in 89.5% patients. This study showed an association of dupA with cagA and vacA s1m1 genotypes but without any link to disease outcome. The difference in the results of these two studies from Brazil could be explained by variation in geographic regions, a re-arrangement in the plasticity zone distribution in H. pylori and various methods used for the analysis.
The distribution of dupA in H. pylori was similar in Iraqi and Iranian population, but there was an association between peptic ulcer and dupA only in the Iraqi population. An independent study by Douraghi et al (2008) reported a non-significant higher distribution of dupA in DU than non-cardia GC patients in the Iranian population. Another study by Talebi Bezmin Abadi et al (2012) found a positive association between the presence of dupA and DU along with an inverse association between dupA and GU in Iranian population. The discrepancy in the finding of Douraghi et al (2008) and Talebi Bezmin Abadi et al (2012) may be due to differences in the study populations. Douraghi et al (2008) focused mainly in Tehran (the densely populated capital of Iran), whereas Talebi Bezmin Abadi et al (2012) collected samples from the extremely rural northern areas of Iran. Recently, Fatahi et al (2019) tested a highly conserved region of dupA and showed a significant relationship between the occurrence of DU and the presence of an 112 bp segment of dupA in the Iranian population. Another group from Iran studied the relationship between antibiotic resistance pattern and virulence genotype among 68 H. pylori strains and found that metronidazole resistance was significantly associated with the strains harboring cagA, sabA and dupA. One study from Kurdistan region of Northern Iraq reported that cagA gene was significantly associated with peptic ulcer disease rather than dupA, which contradict the result of Hussein et al (2008). This might be due to the differences in sample size and also in the geographical location of Iraq. In the Shiraz area of Iran, a significant relationship was found between strains with dupA, CagA motif (ABC types) and DU disease, which supports the previous finding in this region. Another study from Western Iran indicated that presence of dupA gene could be considered as a marker for the onset of severe gastroduodenal diseases. However, there was no association of dupA with DU in the results obtained from the Turkish population.
In China and South Korea, presence of dupA in clinical H. pylori isolates is significantly associated with DU and peptic ulcer (DU, benign GU, dysplasia), respectively[38,39]. In the Taiwanese female population, the host factor matrix metalloproteinase-3/tissue inhibitor matrix metalloproteinase-1 genotypes rather than dupA was found to increase the risk of DU in H. pylori infected cases. A case control study conducted in Sweden, Australia, Malaysia and Singapore showed that there was significant variation in the prevalence of dupA in different locations and among different ethnic groups (Chinese, Indian and Malaya) within a country. Another study in ethnic groups (Indian, Chinese and Malaya) of Malaysia reported that the prevalence of dupA was 22.9% in patients, which was in line with previous data (21.3%) conducted in Malaysia by Schmidt et al (2009). In the later study, there was no association between dupA and clinical outcome.
Two independent systematic review and meta-analyses showed that dupA is more associated with DU in some Asian populations than in Western populations[43,44]. Between 2005 and 2009, almost all the studies used polymerase chain reaction (PCR) of two ORFs jhp0917, jhp0918 and sequencing to identify the dupA. Functional analysis of dupA in the Japanese population showed no association with DU but another study from different parts of Japan showed that dupA is inversely related to GC[45,46].
Results from a study using different molecular methods [PCR, dot-blot hybridization, sequencing and reverse transcription PCR (RT-PCR)] indicated that dupA gene was prevalent more than six times in DU than in non-ulcer dyspepsia patients, indicating its significant association in India. This result also corroborated the finding of Arachchi et al (2007) from North India. The RT-PCR analysis of South and East Indian population revealed that all PCR positive strains were not able to produce dupA transcripts, which was inconsistent with the finding of Nguyen et al (2009) where all the dupA positive strains showed the expression of the gene. Further, the real-time PCR analysis revealed that the expression level of the dupA transcripts varied from strain to strain in this study.
Studies conducted in Chile supported a significant association of dupA gene with non-severe clinical outcome like DU and also played a role in protecting severe diseases like GC. The Costa Rica study with 151 dyspeptic patients showed that presence of dupA was significantly associated with decreased risk of DU.
Some of the above-mentioned studies verified the finding of Lu et al (2005), but others could not find an association between dupA and disease outcome in their study populations. The differences in the results could be explained due to variation in the distribution of plasticity region genes and differences in the study population and techniques chosen for detection of dupA gene. Several studies on dupA were restricted to PCR of jhp0917 and jhp0918 along with sequencing of only the 3' region of jhp0917 to find the insertion of T/C at 1385 position of jhp0917. Numerous studies have shown the presence of frame shift mutation within dupA gene leading to the formation of truncated non-functional DupA. These findings provide evidence that only PCR based analysis of dupA may yield erroneous interpretation. Studies conducted by Queiroz et al (2011) and Moura et al (2012) from Brazil showed the presence of a mutation in dupA that results in a stop codon, making the gene truncated or non-functional. In addition, these studies revealed the importance of sequence analysis of dupA amplicons[50,51]. Truncated dupA might not be involved in the pathogenesis of H. pylori.
Hussein et al (2010) coined the term “dupA1”. The dupA positive H. pylori strains were categorized into two alleles based on the sequence; dupA1 (intact 1884 bp) and dupA2 (truncated). It was shown that the intact dupA1 positive strains induced the production of interleukin (IL)-12 subunit p40 (IL-12p40) and IL-12p70 from CD14 (+) mononuclear cells and IL-8 expression in the human stomach, respectively. Takahashi et al (2012) first reported the presence of an additional 615 bp in the 5' region of ORF jhp0917 (absent in strain J99) and 45 bp in the 3' of jhp0918 (consist of 37 bp of intergenic region of jhp0918-jhp0919 and 8 bp of 5' region of jhp0919 in J99) to make 2499 bp of dupA in the Japanese population (Figure 1). This variation formed the basis for classification of dupA into two types; “long and short types”. The long type of intact 2499 bp (with an additional 615 bp at 5' region of jhp0917) has been considered as an actual virulence factor, and the absence of the additional segment should be interpreted with caution.
Figure 1 Schematic representation of the jhp0917, jhp0918 and jhp0919 gene in strain J99 and that of the dupA alleles in the clinical isolates.
The long type dupA (2499 nt) in some clinical isolates contained an additional 615 nt in 5' region before jhp0917 gene and ended 5 bp after the start codon of jph0919 gene. The short type dupA (1884 nt) in some clinical isolates starts from the 5' region of jhp0917 gene and ended 5 bp after the start codon of jph0919 gene.
None of the H. pylori strains from Iraq carried the complete dupA cluster containing virB8, virB9, virB10, virB11, virD4 and virD2, but there was a significant association between dupA1 and DU. Moreover, higher levels of gastric mucosa IL-8 production were documented in dupA1 than in dupA2 or dupA negative strains. Further studies with H. pylori infected patients showed that cagA, complete dupA cluster and smoking habit were associated with increased levels of IL-8 production from gastric mucosa. It was also shown in another study that the high IL-8 level in gastric mucosa was neither significantly associated with dupA1 positive strains nor with dupA negative strains. A significant association has also been found between dupA1 and A2147G clarithromycin resistance mutation. However, the result of dupA1 and IL-8 association in the Iraqi population was not well elucidated. In Brazilian H. pylori strains, it was found that H. pylori strains had the 45 base at the 3' end of dupA, similar to that of dupA1.
dupA gene of Indian H. pylori strains has been classified into two forms based on the presence of additional 615 bp at the 5' region of dupA followed by a stop codon. This includes dupA1 without any frameshift mutation (either long type or short type) and dupA2 with the truncated version having frameshift mutation. Among these, dupA1 (intact dupA) was significantly associated with DU. Phylogenetic analysis of complete dupA gene sequencing revealed that Indian H. pylori strains intermingled with the East Asian strains, but differed from European strains. dupA is the first known genetic element of Indian H. pylori strains, which phylogenetically formed the same cluster with the East Asian strains. In vitro study showed that IL-8 production was significantly associated with DU in intact dupA1 rather than truncated dupA2 or dupA negative strains. In Chinese strains, the prevalence of long type dupA (2499 bp) was significantly higher in patients with GU, GC and DU than in those with gastritis.
In the Japanese population, prevalence of dupA was higher in the group where H. pylori cannot be eradicated, indicating that dupA may be an associated risk factor in the eradication failure. A study from Pakistan on the influence of dupA in the eradication failure showed that H. pylori strains harboring dupA and cagA were multidrug (metronidazole, clarithromycin and amoxicillin) resistant as compared to strains having other virulence factors. This finding was similar to the observation made in the Japanese population. In the northern part of Spain, dupA was more prevalent in mild diseases (peptic ulcer) than severe diseases (GC). In Switzerland and South Africa, dupA of H. pylori was not associated with severe gastritis or DU[63,64].
DUPA CLUSTER: THIRD TYPE IV SECRETION SYSTEM (T4SS) OF H. PYLORI
The T4SS is an important bacterial transport system, and it is involved in the transport of large molecules (e.g., DNA, protein, etc). across the bacterial cell envelope[65,66]. Till now, three types of T4SS have been identified in H. pylori, of which much work has been done for the first two categories (cagPAI and ComB) and little is known about the third T4SS termed dupA cluster or tfs3 (Figure 2)[67,68]. The third putative type IV secretion system (tfs3) is a 16 kb gene fragment present in the plasticity zone of H. pylori, whose seven ORFs (viB4, virB8, virB9, virB10, virB11, virD4 and virD2) were homologous to virB4/D of Agrobacterium tumefecians (A. tumefecians). The function of the tfs3 elements is not yet clear as there is no direct evidence to show its role in transformation, conjugation or mouse colonization[69,70]. Some researchers divided the tfs3 into tfs3a (all six virB homologues with dupA) and tfs3b (all six virB homologues with virB4), whereas others named all six virB homologues with virB4 as tfs3 and all six virB homologues with dupA as tfs4[71-73]. In order to avoid confusion, we will use the term tfs3a or dupA cluster (all six virB homologues with dupA). VirB8, VirB9 and VirB10 are expected to form the core complex that bridges cytoplasm and the outer membrane. The VirB4, VirB11, VirD4 may be localized to the inner bacterial membrane and recognize the substrate and energize translocation and assembly of T4SS. Further, the novel putative T4SS (tfs3a) or dupA cluster has been divided into three groups: Viz, a complete dupA cluster (dupA-positive and all six virB genes-positive), an incomplete dupA cluster (dupA-positive but one/more than one virB genes negative) and dupA-negative group (dupA negative and virB gene positive/negative).
Figure 2 Organization of three types of type IV secretion system in the Helicobacter pylori compared to Agrobacterium tumefaciens prototype type IV secretion system.
Genes are not drawn to scale. H. pylori: Helicobacter pylori; A. tumefaciens: Agrobacterium tumefaciens; T4SS: Type IV secretion system.
The study of dupA cluster from the United States population showed that the complete dupA cluster (dupA with six virB homologues) was associated with DU rather than dupA gene only. Another report from the northeast part of China showed a significant association of complete dupA cluster with IL-8 production (P < 0.01), but it did not show any correlation between dupA cluster and disease outcome. The studies from United States and China were conducted to check the prevalence of tfs3a or dupA cluster in their population by PCR only. However, the mere presence of the gene does not express functional protein and there is no direct evidence that shows tfs3a or dupA cluster forming a functional T4SS. The earlier studies on tfs3adid not find a direct pathogenic role of tfs3a in H. pylori, but found increased colonization fitness and up-regulation of pro-inflammatory signaling from cultured cells. A novel pathogenicity island (PAI) called tfs3-PAI was identified in China that had 17 ORFs, of which six are functionally homologues of T4SS and coordinate with the well-studied cag-PAI. The complete tfs plasticity cluster was associated with IL-8 induction. The expression of some of the genes of tfs3a/tfs4 (virB2, virB4, virB6, virB8, virB10) in H. pylori is up-regulated in low pH and enhances bacterial adhesion that support the role of tfs3a/tfs4 in the colonization and virulence. It is not known whether the virB genes of dupA cluster work independently or in a coordinated manner by interacting among themselves or complementing each other’s function. We checked the interaction of dupA with six virB genes of tfs3a to identify the assembly and function of complete tfs3 using in vivo studies (yeast two-hybrid system) and found that dupA gene did not interact directly with any virB gene. It seems that dupA may interact with some intermediates or work independently (unpublished data). This interpretation supports our earlier finding that tfs3 is not significantly associated with DU in Indian population. More studies are required to know the structure, assembly and functions of the VirB proteins in H. pylori.
THE PROSPECTIVE FUNCTIONS OF DUPA
The bioinformatics analysis (PDB search tool, UniProt database) showed that the dupA gene is homologous to VirB4 adenosine triphosphate (ATP)ase of virB/virD of A. tumefecians and is predicted to be involved in DNA/protein transfer. The N-terminal of long type DupA has no homologous motif. Only the middle portion (jhp0917) and C-terminal (part of jhp0918) showed homologous motifs suggesting that the N-terminal region might act as signal sequence. The amino acid sequence (210-406 AA) of jhp0917 gene protein was homologous to CagE_TrbE_VirB family, a component of type IV transporter secretion system. The first middle region of the DupA protein (430-500 AA) is homologous to FtsK/SpoIIIE family, which contains ATP binding P-loop motif. This was found in the Ftsk protein of Escherichia coli involved in peptidoglycan synthesis and spoIIIE of Bacillus subtilis, facilitating in the intercellular chromosomal DNA transfer.
The second middle region (464-503aa) is homologous to TrwB, which has an ATP binding domain, and a part of T4SS may be responsible for the DNA binding and horizontal DNA transfer. The C-terminal region (668-738aa) is homologous to TraG_C_D, which is involved in the interaction of DNA-processing (Dtr) and mating pair formation (Mpf) system, leading to DNA transfer in bacterial conjugation. Many reports have shown that the growth rate of dupA positive strains is higher in low pH as compared to dupA deleted/negative strains. This phenomenon indicates that DupA protein acts as an interactive protein and hence regulates urease secretion in H. pylori.
The in vitro and in vivo studies showed the role of dupA gene in the activation of transcription factors nuclear factor kappa light chain enhancer of activated B cells and activator protein-1, which leads to IL-8 production. DupA protein act as an ATPase associated efflux pump, which probably confers its virulence. Evidence suggests that DupA is involved in the pathogenesis of H. pylori by activating the mitochondria dependent apoptotic pathway of the host’s cell, which ultimately inhibits gastric cell growth.
Studies to understand the apoptotic effect of dupA on human gastric adenocarcinoma epithelial cell line (commonly known as AGS) by propidium iodide staining and fragmentation assay determined that dupA gene can induce apoptosis in AGS cells during an early stage of infection (unpublished data). This finding supports the results of Wang et al (2015) and finds that dupA may act as a pathogenic factor of H. pylori to cause gastroduodenal diseases. Further studies are required to confirm the pathogenic effect of dupA in an in vivo model.
The growth kinetics between wild type dupA positive strains and its isogenic mutant strain showed that exponential phase was retarded in dupA mutant cells as compared to the wild type strain. Our growth curve results, supported by the microarray data, showed that cell division gene in the mutant H. pylori was downregulated (unpublished data). It has also been suggested that motility is an essential feature in the colonization and therefore the pathogenicity of H. pylori. The decrease in motility in dupA mutant strain as compared to wild type inferred the role of dupA gene in the motility. This motility result was further confirmed by the gene expression profile of dupA mutant strain whose flagella proteins (FlgE, FliD and FliG) were found to be down-regulated (unpublished data). It might be possible that dupA gene is directly or indirectly involved in negatively affecting the expression of cell division and flagellar genes of H. pylori.
As predicted from the bioinformatics analysis, our experimental data (unpublished data) have shown that natural transformation ability in dupA mutant strains has been totally inhibited in comparison to their wild type counterparts. There is a need for more studies on the heat-shock transformation efficiency, which will confirm the natural transformation assay, if any. Resistance to antimicrobials is of serious concern in H. pylori infection, as this may be the basis for eradication failure. It is important to use therapeutic regimens based on the results of antibiotic susceptibility testing. Metronidazole is considered a key drug in several therapies against H. pylori infection. The results of the metronidazole susceptibility test showed that inactivation of dupA gene transforms the H. pylori strains to resistance phenotype. This phenomenon has not been explained very well. It is possible that the dupA gene might help in the DNA/protein/drug import (unpublished data).
The dupA or dupA cluster may have an intermediate function to link cagPAI and comB system, as dupA gene shows homology with cagE of cagPAI and comB4 of comB system. So, there is a need of an in vivo study to establish the precise function of dupA. It is assumed that the dupA in combination with other six vir genes form a novel third T4SS called tfs3a or dupA cluster that might play a pathogenic role in gastroduodenal diseases.
H. pylori is one of the most diverse bacterial species. H. pylori demonstrate panmictic population structure. DNA-fingerprint of two strains isolated from two different persons generally displays a non-identical pattern, which suggests genetic exchange along with co-evolution of this gastric pathogen with its host. One study from the Indian population demonstrated that all the tested patients carried multiple H. pylori strains in their gastric mucosa. Analyses of certain genetic loci showed the micro diversity among the colonies from a single patient, which may be due to the recombination events during long-term carriage of the pathogen. From the results of this study, researchers predicted that many patients from the developing world acquired infections of H. pylori due to repeated exposure to this pathogen with different genetic make-up. This may enhance the probability of super infections, which favor genetic exchanges among these unrelated H. pylori strains. As a result, this led to the genesis of certain H. pylori variants with different genetic makeup than the parental strain, which in turn increases the chance of the severe infection. Therefore, the exploration of appropriate biomarker(s) that envisage the clinical condition in H. pylori-infected patient is a challenging area of research.
There is a lack of relevant biomarker(s) capable of predicting important digestive diseases in clinical settings. Even though there is ample information regarding the dupA of H. pylori, many unanswered questions still exist, especially regarding the specificity of the dupA proposed for clinical manifestation. dupA was categorized as long and short types in one study, but in another study, this gene was typed as dupA1 (intact dupA1 may be long type or short type) and dupA2 (truncated version). This gene classification should be resolved for international use to avoid any misperception. We propose the long dupA as dupA1 and short type dupA as dupA2, and the truncated version of dupA has to be disregarded, as it has no role in pathogenesis. dupA should be screened by PCR, sequencing of the full-length gene (1884 and 2499 nt) and western blotting. Nevertheless, the discrepancy prevails between the association of dupA (short type or long type) or dupA cluster and the disease outcome. Currently, the prevalence of intact dupA in East Asian countries is lower than Western countries. DupA with another six Vir proteins (VirB8, VirB9, VirB10, VirB11, VirD4 and VirD2) predicted to form novel third type-IV secretion system (tfs3a), which may be involved in transformation/conjugation or injection of DNA/new effector molecules in gastric epithelial cells. However, the function of specific Vir protein of complete dupA cluster (tfs3a) is not well characterized. Recent reports and other unpublished data showed that DupA has multifunctional biological activities, and it can be considered as an important biomarker for DU. It is also not clear whether the DupA works alone or in combination with other VirB proteins. There is an urgent need for reliable in vitro and animal models from diverse geographical areas of the world to elucidate further the pathogenic role of dupA and dupA cluster in gastroduodenal diseases, particularly the DU and GC.
Pellicano R, Ribaldone DG, Fagoonee S, Astegiano M, Saracco GM, Mégraud F. A 2016 panorama of Helicobacter pylori infection: key messages for clinicians.Panminerva Med. 2016;58:304-317.
[PubMed] [DOI][Cited in This Article: ]
Talaei R, Souod N, Momtaz H, Dabiri H. Milk of livestock as a possible transmission route of Helicobacter pylori infection.Gastroenterol Hepatol Bed Bench. 2015;8:S30-S36.
[PubMed] [DOI][Cited in This Article: ]
Souod N, Sarshar M, Dabiri H, Momtaz H, Kargar M, Mohammadzadeh A, Abdi S. The study of the oipA and dupA genes in Helicobacter pylori strains and their relationship with different gastroduodenal diseases.Gastroenterol Hepatol Bed Bench. 2015;8:S47-S53.
[PubMed] [DOI][Cited in This Article: ]